Literature DB >> 7000694

Amyloid P-component in mice injected with casein: identification in amyloid deposits and in the cytoplasm of hepatocytes.

M L Baltz, R F Dyck, M B Pepys.   

Abstract

Amyloid P-component was sought by immunofluorescence in the tissues of CBA mice receiving repeated subcutaneous injections of casein. P-component appeared in a perifollicular distribution in the spleen after about twenty casein injections, and correlated precisely with amyloid deposits identified by staining with Congo red. In mice which had received at least fourteen injections of casein, P-component also became detectable within the cytoplasm of periportal hepatocytes. This is the first demonstration of P-component in murine amyloid and of a possible site for in vivo synthesis of P-component.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000694      PMCID: PMC1458246     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

Authors:  A P Osmand; B Friedenson; H Gewurz; R H Painter; T Hofmann; E Shelton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

2.  The ultrastructure of human amyloid as revealed by the negative staining technique.

Authors:  H A Bladen; M U Nylen; G G Glenner
Journal:  J Ultrastruct Res       Date:  1966-03

3.  Immunofluorescence counterstains.

Authors:  E A Schenk; C J Churukian
Journal:  J Histochem Cytochem       Date:  1974-10       Impact factor: 2.479

4.  Analogues in other mammals and in fish of human plasma proteins, C-reactive protein and amyloid P component.

Authors:  M B Pepys; A C Dash; T C Fletcher; N Richardson; E A Munn; A Feinstein
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

5.  The identification of amyloid P-component (protein AP) in normal cultured human fibroblasts.

Authors:  E C Spark; T Shirahama; M Skinner; A S Cohen
Journal:  Lab Invest       Date:  1978-05       Impact factor: 5.662

6.  Experimental amyloidosis. Role of antigenicity and rapid induction.

Authors:  D T Janigan; R L Druet
Journal:  Am J Pathol       Date:  1966-06       Impact factor: 4.307

7.  Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.

Authors:  M B Pepys; A C Dash; R E Markham; H C Thomas; B D Williams; A Petrie
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

8.  The P-component of amyloid of human islets of langerhans.

Authors:  P Westermark; M Skinner; A S Cohen
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

9.  P-component of amyloid. Isolation from human serum by affinity chromatography.

Authors:  M D Benson; M Skinner; T Shirahama; A S Cohen
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug

10.  Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit.

Authors:  I Kushner; G Feldmann
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  8 in total

1.  Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?

Authors:  M L Baltz; I F Rowe; D Caspi; W G Turnell; M B Pepys
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

2.  The failure of ascorbic acid therapy to alter the induction or remission of murine amyloidosis.

Authors:  M L Baltz; D Caspi; B E Glatthaar; U Moser; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

3.  Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.

Authors:  M L Baltz; D Caspi; D J Evans; I F Rowe; C R Hind; M B Pepys
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

4.  Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse.

Authors:  M L Baltz; R F Dyck; M B Pepys
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

5.  Acute phase serum proteins in syngeneic and allogeneic mouse pregnancy.

Authors:  G T Waites; A M Bell; S C Bell
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

6.  Mouse hepatocyte synthesis and induction of the acute phase reactant: serum amyloid P-component.

Authors:  P T Le; R F Mortensen
Journal:  In Vitro       Date:  1984-06

7.  Amyloid P-component is a constituent of normal human glomerular basement membrane.

Authors:  R F Dyck; C M Lockwood; M Kershaw; N McHugh; V C Duance; M L Baltz; M B Pepys
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

8.  Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice.

Authors:  Tejas R Karhadkar; Darrell Pilling; Richard H Gomer
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.